Related Experiment Video
Updated: Feb 22, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.7K
Fibrinolysis in trauma: a review.
M J Madurska1, K A Sachse2, J O Jansen3
1Department of Vascular Surgery, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK. martamadurska@hotmail.com.
Summary
Fibrinolytic dysregulation in traumatic coagulopathy, including hyperfibrinolysis and shutdown, increases mortality. Viscoelastic studies may aid timely diagnosis, but treatment remains controversial.
Area of Science:
- Coagulation and Hemostasis
- Trauma Pathophysiology
- Fibrinolysis
Background:
- Fibrinolytic dysregulation is a key factor in traumatic coagulopathy, with implications for patient outcomes.
- This dysregulation encompasses both excessive breakdown (hyperfibrinolysis) and impaired fibrinolysis (shutdown).
- Both extremes are linked to increased mortality and organ failure post-trauma.
Purpose of the Study:
- To review the current evidence on the pathophysiology of fibrinolytic dysregulation in trauma.
- To discuss the diagnostic challenges and potential of viscoelastic studies.
- To examine the multimodal management strategies and controversies in antifibrinolytic therapy.
Main Methods:
- Literature review of current evidence.
- Analysis of pathophysiology, diagnostic modalities, and treatment strategies.
- Focus on fibrinolytic dysregulation in the context of traumatic coagulopathy.
Main Results:
- Fibrinolytic dysregulation is multifactorial, involving endothelial injury and hypoperfusion.
- Viscoelastic studies show promise for rapid identification of fibrinolytic abnormalities.
- Treatment is complex, with ongoing debate regarding antifibrinolytic agents.
Conclusions:
- Fibrinolytic dysregulation significantly impacts trauma outcomes.
- Timely diagnosis via viscoelastic studies is crucial.
- Management requires a multimodal approach, with careful consideration of antifibrinolytic therapy.
Related Concept Videos
Clot Retraction and Fibrinolysis
9.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.5K
Extrinsic and Intrinsic Pathways of Hemostasis
13.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.8K
Coagulation
11.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.1K
Introduction to Hemostasis
15.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
15.1K
Flail Chest-II
713
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
713
Phases of Wound Repair
9.0K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
9.0K

